arrow
F

Fabienne Desmots

INSERM
H指数:22
被引数:1,368

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma

Camus, V.; Molina, T.J.; Desmots, F.; Blanc-Durand, P.; Kanoun, S.; Moslemi, A.; Ruminy, P.; Le Gouill, S.; Ghesquieres, H.; Obéric, L.; et al. 4个周期后的中期PET预测组织分子学确诊的原发性纵隔B细胞淋巴瘤的结局。Blood Adv. 2025, 9, 2232–2246. [Google Scholar] [CrossRef] [PubMed]

2025-01-010
OAAI
The Negative Influence of Baseline Cell-free DNA on Long-term Survival in DLBCL Depends on Frontline Treatment Intensity
2023-04-040
OA
Committed Human CD23-Negative Light-Zone Germinal Center B Cells Delineate Transcriptional Program Supporting Plasma Cell Differentiation

人类CD23-Negative光区生发中心b细胞描绘支持浆细胞分化的转录程序

2021-12-028
OAAI
Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases
2017-04-3097
OAAI
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study
2016-06-14174
OAAI
Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis
2015-03-0668
OAAI